Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 293

Related Citations for PubMed (Select 14680418)

1.

Clinical guidelines: Dosing and switching strategies for long-acting risperidone.

Marder SR, Conley R, Ereshefsky L, Kane JM, Turner MS.

J Clin Psychiatry. 2003;64 Suppl 16:41-6. No abstract available.

PMID:
14680418
2.

Initial dosing strategies for long-acting injectable risperidone.

Viner MW, Matuszak JM, Knight LJ.

J Clin Psychiatry. 2006 Aug;67(8):1310-1. No abstract available.

PMID:
16965217
3.

Injection site pain with long-acting risperidone.

Pinninti NR, Mago R.

J Clin Psychiatry. 2005 May;66(5):656-7; author reply, 657. No abstract available.

PMID:
15889958
6.

A cross-sectional study of plasma risperidone levels with risperidone long-acting injectable: implications for dopamine D2 receptor occupancy during maintenance treatment in schizophrenia.

Ikai S, Remington G, Suzuki T, Takeuchi H, Tsuboi T, Den R, Hirano J, Tsunoda K, Nishimoto M, Watanabe K, Mimura M, Mamo D, Uchida H.

J Clin Psychiatry. 2012 Aug;73(8):1147-52. doi: 10.4088/JCP.12m07638.

PMID:
22967779
7.

Academic highlights: guidelines for the use of long-acting injectable atypical antipsychotics.

Keith SJ, Kane JM, Turner M, Conley RR, Nasrallah HA.

J Clin Psychiatry. 2004 Jan;65(1):120-31. No abstract available.

PMID:
14744181
8.
9.

Risperidone long-acting injection in practice - more questions than answers?

Taylor D.

Acta Psychiatr Scand. 2006 Jul;114(1):1-2. No abstract available.

PMID:
16774654
10.

The impact of insight on functioning in patients with schizophrenia or schizoaffective disorder receiving risperidone long-acting injectable.

Gharabawi G, Bossie C, Turkoz I, Kujawa M, Mahmoud R, Simpson G.

J Nerv Ment Dis. 2007 Dec;195(12):976-82.

PMID:
18091190
11.

Acute dystonic reaction with risperidone.

Takhar J, Manchanda R.

Can J Psychiatry. 1996 Feb;41(1):61-2. No abstract available.

PMID:
8919428
12.

Long-acting risperidone in young adults with early schizophrenia or schizoaffective illness.

Lasser RA, Bossie CA, Zhu Y, Locklear JC, Kane JM.

Ann Clin Psychiatry. 2007 Apr-Jun;19(2):65-71.

PMID:
17612845
13.

Leukopenia during therapy with risperidone long-acting injectable: two case reports.

Uzun S, Kozumplik O, Jakovljević M, Folnegović-Smalc V.

J Clin Psychopharmacol. 2008 Dec;28(6):713-4. doi: 10.1097/JCP.0b013e31818b53a1. No abstract available.

PMID:
19011449
14.

Clozapine versus risperidone in treatment-refractory schizophrenia: possible impact of dosing strategies.

Lane HY, Chang WH.

J Clin Psychiatry. 1999 Jul;60(7):487-8. No abstract available.

PMID:
10453806
15.
16.

Remission in patients with first-episode schizophrenia receiving assured antipsychotic medication: a study with risperidone long-acting injection.

Emsley R, Oosthuizen P, Koen L, Niehaus DJ, Medori R, Rabinowitz J.

Int Clin Psychopharmacol. 2008 Nov;23(6):325-31. doi: 10.1097/YIC.0b013e32830c2042.

PMID:
18854720
17.

Antipsychotic medication in the treatment of schizophrenia.

Kane JM.

Isr J Psychiatry Relat Sci. 1995;32(1):30-7. Review.

PMID:
7542642
18.

Monthly administration of long-acting injectable risperidone and striatal dopamine D2 receptor occupancy for the management of schizophrenia.

Uchida H, Mamo DC, Kapur S, Labelle A, Shammi C, Mannaert EJ, Mann SW, Remington G.

J Clin Psychiatry. 2008 Aug;69(8):1281-6.

PMID:
18642974
19.

Clinical review of a long-acting, injectable formulation of risperidone.

Knox ED, Stimmel GL.

Clin Ther. 2004 Dec;26(12):1994-2002. Review.

PMID:
15823763
20.

Galantamine augmentation of long-acting injectable risperidone for cognitive impairments in chronic schizophrenia.

Lindenmayer JP, Khan A.

Schizophr Res. 2011 Feb;125(2-3):267-77. doi: 10.1016/j.schres.2010.08.021. Epub 2010 Sep 17.

PMID:
20850275
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk